Carcinoma, Non-Small Cell Lung Clinical Trials in Xuzhou, Jiangsu

This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.